Nasdaq biol.

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery...SWK Holdings Highlights Recent Achievements and Provides Portfolio Update PR Newswire DALLAS, Oct. 18, 2023 DALLAS, Oct. 18, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ('SWK' or t...LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...

IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group ...4 Oct 2012 ... Nasdaq: BIOL. PAGE 1. Exhibit 99.1. The BIOLASE. Total Solution. The ... Eliminates accidental sticks with contaminated burs. BIOLASE'S Waterlase ...

BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript (Insider Monkey)-7.63%. Mar-28-23 04:16PM Biolase: Q4 Earnings Snapshot (AP Finance) 04:05PM BIOL Biolase Inc BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022

FOOTHILL RANCH, Calif., March 25, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...BIOL Biolase Inc BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.Jan 6, 2022 · FOOTHILL RANCH, Calif., Jan. 6, 2022 /PRNewswire/-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...

BIOLASE, Inc. (NASDAQ:BIOL) fell 10% to $1.35 in pre-market trading. Biolase shares jumped 44% on Tuesday after the company announced Q4 preliminary sales guidance above analyst estimates..

On Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge into U.S. public markets. Korro's stock price soared …

Webull offers Biolase Inc (BIOL) historical stock prices, in-depth market analysis, NASDAQ: BIOL real-time stock quote data, in-depth charts.Biolase: Q1 Earnings Snapshot. (AP Finance) +26.33%. 04:21PM. BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER …The stock was up 8.89% to $3.43 in after-hours trading. Agios Reports Positive Phase 3 Data For Mitapivat In Treating Genetic Blood Disorder. Agios Pharmaceuticals Inc (NASDAQ:AGIO) said that the ...FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned ...Gainers BIOLASE, Inc. (NASDAQ:BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said i...

Earnings announcement* for BIOL: Nov 09, 2022. Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical ...BIOLASE's CEO is John Beaver, appointed in Feb 2021, has a tenure of 2.75 years. total yearly compensation is $733.09K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $152.65. The average tenure of the management team and the board of directors is 2 years ...The BIOL share has a YTD performance of -22% and a 52-week price range of $0.37 - $10.4. The stock has experienced positive momentum due to a solid revenue report in Q4 2022. With a stock price below $1, the stock may provide great value to investors considering a positive outlook for 2023. Best place to buy BIOL: RobinhoodLAKE FOREST, Calif., Feb. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition to the Top Workplaces 2022 honor from the Orange County Register, which …According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ...BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...

Home BIOL • NASDAQ BIOLASE Inc Follow Share $1.15 Dec 1, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to T2 Biosystems Inc $3.90 TTOO10.17% Assertio Holdings Inc $1.14...

Nov 24, 2021 · At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ... FOOTHILL RANCH, Calif., March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to ...LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. BIOLASE down 30%, prices $4.5M stock offering (NASDAQ:BIOL) From ...15 May 2021 ... BIOLASE (NASDAQ:BIOL) Share Prices Have Dropped 88% In The Last Five Years ... Some stocks are best avoided. We really hate to see fellow ...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...

BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript (Insider Monkey)-7.63%. Mar-28-23 04:16PM Biolase: Q4 Earnings Snapshot (AP Finance) 04:05PM

LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day …

Nov 27, 2023 · The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ... LAKE FOREST, Calif., Aug. 24, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced it has been invited to present at the Lake Street 6 th Annual ...BIOLASE, Inc. 30 Mar, 2021, 09:00 ET. FOOTHILL RANCH, Calif., March 30, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced a pilot program with ...IRVINE, Calif., July 2, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If ...LAKE FOREST, Calif., Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11 th Annual ...Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ...BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...2 analysts have issued 1-year price objectives for BIOLASE's shares. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's stock price to reach $77.00 in the next year. …

Feb 10, 2022 · The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ... FOOTHILL RANCH, Calif., Jan. 6, 2022 /PRNewswire/-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition ...Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Instagram:https://instagram. cheapest way to invest in real estateoption serviceharrison financial servicesvnla etf Nov 17, 2021 · BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ... credit card delinquencyswag management platform BIOL Biolase Inc stock NASDAQ ... Shares Out. ... biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in ... stock ddd BIOLASE's CEO is John Beaver, appointed in Feb 2021, has a tenure of 2.75 years. total yearly compensation is $733.09K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $152.65. The average tenure of the management team and the board of directors is 2 years ...Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies StocksBIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...